MENU CLOSE

Our Mission:

Accelerating a Cure

for Multiple Myeloma

The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient.

We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches and empower myeloma patients and the broader community with information and resources to extend their lives.

The latest from The MMRF

MMRF Blogs
Default blog news press Sarclisa (isatuximab): A New Option for Patients With Newly Diagnosed Myeloma Not Eligible for Transplant
MMRF in the News
With Plethora Of New Myeloma Treatments, MMRF Study Aims To Better Guide Use
MMRF Blogs
Default blog news press MMRF Patient Navigator Q&A: Nursing Insights From the NCCN and JADPRO Annual Meetings
MMRF Press Releases
Default blog news press Indapta Therapeutics Secures $22.5 Million to Advance Clinical Trials of Innovative Cancer and Autoimmune Treatments
MMRF Press Releases
Default blog news press Multiple Myeloma Research Foundation Partners with Family Reach to Deliver Critical Financial Support to Multiple Myeloma Patients and their Families
MMRF Blogs
Default blog news press MMRF ASH 2024 Blog: Day 3
MMRF Blogs
Default blog news press MMRF ASH 2024 Blog: Day 2
MMRF Blogs
Default blog news press MMRF ASH 2024 Blog: Day 1
MMRF Press Releases
Default blog news press Multiple Myeloma Research Foundation (MMRF) Programs Power New Insights into High-Risk Multiple Myeloma at the 66th American Society of Hematology Annual Meeting

Unprecedented Results

The MMRF’s patient-centered approach is changing cancer research. We’re problem solvers and innovators. Over the years, we’ve found original and creative ways to speed research, build collaborations, and break through institutional barriers that can slow progress.  Our unrelenting focus is on helping every patient find the right treatment.

$600M+

Raised for research

~100

Clinical trials

15+

Drugs brought to market

3X

Increase in life expectancy

About the MMRF

Our Work

Our work is guided by three core pillars: accelerate the development of novel therapies, drive optimal and more personalized treatment approaches, and empower patients and the myeloma community. Central to our mission is a commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue.

Education Hub

Explore our publications, one-pagers, videos, podcasts, and much more to add to your knowledge of multiple myeloma treatment options and related topics. We have a collection of valuable resources to help you along every step of your multiple myeloma journey.

Myeloma Investment Fund® (MIF)

The Myeloma Investment Fund (MIF) accelerates new therapies for myeloma patients. The MIF identifies and invests in the most promising biotechnology companies transforming myeloma treatment.

Ways to Get Involved

Team for Cures

By joining the MMRF Team for Cures, you help accelerate a cure for each and every multiple myeloma patient.

Participants in the MMRF Team for Cures.
Patients participating in myeloma research.

Moving Myeloma Research Forward

Help us unlock vital answers in multiple myeloma research. Your involvement in research carries with it the potential to discover more effective treatments and save more lives.

MMRF Patient Toolkit
Download a comprehensive myeloma toolkit to guide you in your journey.

Get Your Free Toolkit